ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Cost of Revenue for 6 consecutive years, with $382113.0 as the latest value for Q4 2021.
- Quarterly Cost of Revenue rose 98.58% to $382113.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2021, up 84.81% year-over-year, with the annual reading at $189470.0 for FY2025, 66.82% down from the prior year.
- Cost of Revenue for Q4 2021 was $382113.0 at ENDRA Life Sciences, up from $275565.0 in the prior quarter.
- The five-year high for Cost of Revenue was $382113.0 in Q4 2021, with the low at -$245364.0 in Q4 2019.
- Average Cost of Revenue over 5 years is $120546.6, with a median of $118270.0 recorded in 2017.
- The sharpest move saw Cost of Revenue soared 8413.48% in 2018, then tumbled 193.42% in 2019.
- Over 5 years, Cost of Revenue stood at $3085.0 in 2017, then skyrocketed by 8413.48% to $262641.0 in 2018, then crashed by 193.42% to -$245364.0 in 2019, then skyrocketed by 178.42% to $192424.0 in 2020, then surged by 98.58% to $382113.0 in 2021.
- According to Business Quant data, Cost of Revenue over the past three periods came in at $382113.0, $275565.0, and $256763.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.